Author/Authors :
Nelson، نويسنده , , William G. and Haffner، نويسنده , , Michael C. and Yegnasubramanian، نويسنده , , Srinivasan، نويسنده ,
Abstract :
In the May 26th issue of the New England Journal of Medicine, de Bono et al. report that the inhibition of androgen synthesis by abiraterone acetate prolonged the survival of men with prostate cancer previously treated by androgen suppression.
